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Abstract  
AIM: We aim to define the correlations between nephrolithiasis, hypertension, age and obesity in 
patients with autosomal dominant polycystic kidney disease (ADPKD) in Albania.  
MATERIAL AND METHODS: We included 100 patients with autosomal dominant polycystic kidney 
from 2011 to 2014. The patients underwent X-ray and renal ultrasonography. We performed the 
metabolic evaluation of blood and urine. 
RESULTS: The patients with renal stones had a higher level of mean systolic and diastolic blood 
pressure compared with patients without stones (155 ± 12 mmHg vs. 145 ± 8 mmHg, and 105 ± 0.9 
mmHg vs. 92 ± 1.28 mmHg, respectively). Patients with renal stones were older (47 ± 15 vs. 38 ± 5 
years), had a higher prevalence of obesity [body mass index (BMI): 28 ± 2.4 vs. 25.7 ± 0.6], had 
higher levels of total cholesterol level (220 ± 5 mg/dl vs. 203 ± 4 mg/dl) as well as triglyceride levels 
(160 ± 9 mg/dl vs. 126 ± 4 mg/dl), compared with no renal stone individuals.  
CONCLUSION: ADPKD patients with renal stones in our study had a higher mean level of systolic 
and diastolic blood pressure, BMI and cholesterol and triglycerides levels compared with individuals 
without renal stones.   
 
 
 
 
 
Introduction 
 
Nephrolithiasis is an important manifestation 
of autosomal dominant polycystic kidney disease 
(ADPKD), which ranges from 8% to 36% in different 
studies [1-10], about twice higher than in general 
population.  
Most ADPKD patients affected by 
nephrolithiasis are above 40 years old. The disease 
frequency begins to rise between 20-40 years, making 
very uncommon finding nephrolithiasis under the age 
of 20 years [11, 12]; even so there are studies that 
have found cases of nephrolithiasis in ADPKD under 
the age of 20 years [9, 13].  
Recent reports suggest that the etiology of 
stone disease in ADPKD is multifactorial in nature, 
including both anatomic and metabolic factors, and a 
combination of these factors [6, 7, 9, 11, 12, 14]. 
Hypertension and obesity are also social diseases 
with important epidemiological similarities to 
nephroloithiasis. Various studies have demonstrated 
high calciuria in hypertensives with a linear 
relationship between 24-h calciuria and arterial blood 
pressure.  
Also, body mass index (BMI) and body weight 
are independently associated with an increase in 
stone risk even though, due to a number of bias 
(limited weight categories, low number of obese 
persons in the study populations, no control group, no 
recording of food intake) the studies published failed 
to be conclusive.  
We aim to define the correlations between 
nephrolithiasis, hypertension, age and obesity in 
patients with ADPKD in Albania. 
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Material and Methods  
 
We included 100 patients with autosomal 
dominant polycystic kidney from 2011 to 2014 in a 
prospective controlled study. The ethic committee of 
the Faculty of Medicine had approved the study. The 
patients underwent X-ray and renal ultrasonography. 
We performed the metabolic evaluation of blood and 
urine. The diagnosis for ADPKD is done based on 
criteria established by Ravine et al. in 1994 [15]: the 
presence of three or more (unilateral
 
or bilateral) renal 
cysts for individuals aged between 15 to
 
39 years, two 
or more cysts in each kidney for individuals aged
 
40 to 
59 years, and four or more cysts in each kidney for 
individuals over 60 years old. 
All patients underwent renal ultrasound to 
determine cyst number and predominant cyst size. 
Patients with nephrolithiasis were defined as those 
with stones within the collecting system. To diagnose 
renal stones we used all imaging methods, renal 
ultrasound (identification of an echogenic focus with 
posterior acoustic shadowing within the kidney), plain 
abdominal kidney–ureter–bladder film (KUB) for 
radiopaque stones, intravenous pyelography (more 
rarely), which can provide both anatomical and 
functional information on stones and the urinary tract 
and non-contrast helical computed tomography (CT) 
scan in cases when nephrolithiasis was not observed 
by KUB or renal ultrasound. 
Subjects were considered normotensive if 
they had not taken medication for hypertension, the 
mean of three systolic reading was less than 140 
mmHg, and the mean of three diastolic reading was 
less than 90 mmHg at baseline [16, 17].  
Table 1: Demographic data of patients 
 Patients with 
nephrolithiasis 
(58 patients) 
Patients without 
nephrolithiasis 
(42 patients) 
 
P 
value 
Age  47 ± 15 years 38 ± 5 years <0.05 
Sex 
       Females/Males 
 
39/19 
 
19/23 
 
NS 
Area of origin 
       Rural area/Citizen area 
 
40/18 
 
28/14 
 
<0.001 
Renal function  
GFR≥60 ml/min/GFR<60 
ml/min 
 
42/16 
 
 
30/12 
 
NS 
 
BMI (kg/m
2
) 28 ± 2.4 25.7 ± 0.6 <0.05 
Smoking (Yes/No) 18/40 19/33 NS 
Mean blood pressure values 
(mmHg) 
      Mean systolic pressure 
      Mean diastolic pressure 
 
 
155 ± 12 
105 ± 0.9 
 
 
 
145 ± 8 
92 ± 1.28 
 
 
<0.05 
GFR- glomerular filtration rate, BMI- body mass index, NS- not significant.  
 
All variables are presented as mean ± SD. 
Differences were considered significant at the p < 0.05 
levels. 
Pearson's correlation was used in order find 
the associations between diastolic blood pressure and 
kidney size. 
 
Results  
 
Nephrolithiasis was present in 58 of our 
patients with ADPKD (58%). Thirty-nine patients with 
kidney stones were women (Table 1). The stones 
were composed primarily of urate (47%) and calcium 
oxalate (39%), and other compounds 14%. Sixty-six 
per cent of patients with nephrolithiasis (38 patients) 
had hypertension and 40% of them had increased 
BMI. The patients with renal stones had a higher level 
of mean systolic and diastolic blood pressure 
compared with patients without stones (155 ± 12 
mmHg vs. 145 ± 8 mmHg, and 105 ± 0.9 mmHg vs. 
92 ± 1.28 mmHg, respectively). Patients with renal 
stones were older (47 ± 15 vs. 38 ± 5 years), had a 
higher prevalence of obesity (mean BMI: 28 ± 2.4 vs. 
25.7 ± 0.6), had higher levels of total cholesterol level 
(220 ± 5 mg/dl vs. 203 ± 4 mg/dl) as well as 
triglyceride levels (160 ± 9 mg/dl vs. 126 ± 4 mg/dl), 
compared with no renal stone individuals. Ten 
patients were with diabetes mellitus; from there 6 
patients were with stones from uric acid and all of 
them with increased BMI.  
Table 2: The correlation of hypertension with kidney size and 
renal volume 
 Hypertensive 
patients 
Normotensive 
patients 
Pearson’s correlation P value 
Kidney size 16.31 ± 1.7 cm 12.4 ±1 cm r=0.60 <0.039 
Mean renal volume 580 ± 41 cm3 360 ± 42 cm3 r=0.75 <0.005 
 
The kidney size (longitudinal diameter) was 
significantly greater in the hypertensive patients 
compared with those normotensive (16.31 ± 1.7 cm 
vs. 12.4 ± 1 cm, p < 0.039) (Table 2). Systolic and 
diastolic blood pressure correlated with kidney size (p 
< 0.05; r = 0.55; r = 0.63). Also, mean renal volume 
was significantly greater in the hypertensive patients 
versus the normotensive patients (580 ± 41 cm
3
 vs. 
360 ± 42 cm
3
, p < 0.005) (Table 3). 
Table 3: The correlation of blood pressure with kidney size 
Blood pressure Mean ± SD Kidney size Pearson’s 
correlation 
P value 
Systolic blood 
pressure 
155 ± 12 16.8 ± 1.2 cm R = 0.55 0.04 
Diastolic blood 
pressure 
105 ± 0.9 11.5 ± 0.9 cm R = 0.63 0.03 
 
 
Discussion 
 
Our study confirmed that incidence of stone 
disease is greater in hypertensives than in 
normotensives also in ADPKD patients. By the same 
token, the incidence of hypertension is greater in 
stone formers than in non stone formers, but it is not 
clear whether nephrolithiasis is a risk factor for 
hypertension or vice versa. It has been suggested a 
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relationship between structural deformation and 
hypertension in the ADPKD patients [18]. In the 
present study, hypertension was associated with 
greater renal structural abnormalities. Specifically, the 
hypertensive ADPKD patients have greater renal 
volumes and cystic involvement than well-matched 
normotensive ADPKD patients. This supports the 
hypothesis that cyst decompression has been 
associated with a decrease in blood pressure and an 
improvement of renal function [19, 20].  
Metabolic factors are equally important in the 
stone forming process, as are anatomical anomalies 
in ADPKD. Gambaro et al. observed that metabolic 
disturbances were more frequent in stone-forming 
patients with renal anatomical anomalies [7]. 
Uric acid and calcium stones are the most 
frequent types of stones in ADPKD patients even 
though hyperuricosuria and hypercalciuria do not 
occur consistently in ADPKD patients [6, 10]. Umbreit 
et al. in his study also found that 55% of treated 
stones in ADPKD were primarily uric acid calculi [21]. 
Meanwhile, Daudon found that uric acid stones are 
the predominant type in cystic renal abnormalities 
[22]. The reason for this predominance of uric stones 
in this kind of patients is still a debate because of the 
low prevalence of hyperuricosuria (18-28%) in ADPKD 
with normal renal function [4, 13], and more over the 
lack of statistically difference in uricosuria between 
ADPKD patients with or without lithiasis [9]. The 
metabolic abnormalities in these patients include 
hypocitraturia, hyperuricosuria, hyperuricemia and 
presence of diabetic patients among them with stones 
from uric acid confirm the relationship between 
diabetes, hyperuricemia, metabolic syndrome, 
increased BMI and nephrolithiasis. 
On the other hand, in the high frequency of 
nephrolithiasis in ADPKD patients contribute some 
non intrinsic factors such socioeconomic status of 
patients, geographic zones and dietary habits (most of 
them were from rural areas, consuming less water, 
more vegetable and animal proteins) [13].  
In the final analysis, stone disease, arterial 
hypertension and excess weight/obesity prove to be 
closely interconnected and it is possible to intervene 
with targeted diets aimed at reducing the risk of illness 
and death from these diseases. 
 In conclusion, future studies in Albania should 
include larger population-representative samples. The 
association between nephrolithiasis and hypertension 
in patients with ADPKD is important in our patients. 
Except anatomic and metabolic factors, there are 
other contributor factors to this association like dietary 
habits. Both hypertension and stones might be 
addressed through lifestyle modification to prevent 
weight gain. 
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